ONCOZEN Co.

BiotechnologySeedCheongju-si, South Koreaoncozen.co.kr

Latest round

Seed

Last raised

Sep 2020

Total raised

$0.2M

Investors

1

About ONCOZEN Co.

, Ltd. specializes in oncology therapies. Joo-hoon Ahn serves as both CEO and Founder, leading the company with a focus on addressing unmet medical needs in cancer treatment., Ltd. specializes in innovative oncology-focused therapies aimed at treating cancer and rare diseases. Its core product offerings center around a novel technology that leverages the body’s Ubiquitin Proteasome System (UPS) to target and degrade disease-causing proteins mediated by Chaperone complexes. This modality is designed to eliminate proteins linked to various malignancies, addressing significant unmet medical needs. ONCOZEN’s therapies are intended for clinical and research settings, catering to healthcare providers, research institutions, and pharmaceutical partners, primarily in Asia while also exploring North American and European markets., Ltd. reported a revenue of KRW 210 million in 2023, reflecting its business model structured around strategic partnerships and collaborations, including potential direct sales of its proprietary therapeutic products. In addition, the company aims to expand into North American and European markets by 2025, seeking to leverage its existing technologies and collaborations to introduce its innovative therapies to a broader audience.

Who invested in ONCOZEN Co.

1 investor across 1 round

See all investors in ONCOZEN Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Sep 29, 2020

    Amount

    $0.2M

    Investors

    Locked

Questions about ONCOZEN Co.

Who invested in ONCOZEN Co.?

ONCOZEN Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ONCOZEN Co. raised?

ONCOZEN Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did ONCOZEN Co. last raise money?

ONCOZEN Co.'s most recent round on record is a Seed, in Sep 2020.

What does ONCOZEN Co. do?

ONCOZEN Co. is a biotechnology company.

Where is ONCOZEN Co. headquartered?

ONCOZEN Co. is headquartered in Cheongju-si, South Korea.

Which VCs invest in companies like ONCOZEN Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ONCOZEN Co.'s stage. Their profiles are linked below.

Raising like ONCOZEN Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.